![]() Authors may use MDPI'sĮnglish editing service prior to publication or during author revisions. Submitted papers should be well formatted and use good English. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Please visit the Instructions for Authors page before submitting a manuscript. ![]() Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. All manuscripts are thoroughly refereed through a single-blind peer-review process. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). ![]() For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Research articles, review articles as well as short communications are invited. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. All submissions that pass pre-check are peer-reviewed. Manuscripts can be submitted until the deadline. Once you are registered, click here to go to the submission form. Manuscripts should be submitted online at by registering and logging in to this website. In this Special Issue, we invite researchers to provide original research articles, as well as review articles focusing on multiple issues, such as the obtaining, characterization, structure, and original aspects about biomaterials for drug delivery, possibly revealing novel design technologies, advantages, disadvantages, and their various medical applications. Due to their size, nanoparticles have the advantage of reaching otherwise less accessible sites in the body. The important technological advantages of nanoparticles used as drug carriers have high stability, high carrier capacity, feasibility of incorporation of both hydrophilic and hydrophobic substances, and feasibility of variable routes of administration. Nanoparticle drug carriers consist of solid biodegradable particles ranging in size from 0.1 to 100 nm in which the active principle is dissolved, entrapped or encapsulated, and/or to which the active principle is absorbed or attached. Using diverse materials at the nanometer scale, nanotechnology will allow specific and more personalized diagnosis and treatment of different pathologic areas such as cardiovascular diseases, cancer, inflammatory diseases, neurodegenerative syndromes such as Alzheimer’s or Parkinson’s disease, and psychiatric disturbances. The applications of nanotechnology in substance delivery systems development have opened up new areas of research in the sustained release of various drugs. Nanomedicine offers multiple interesting possibilities of nanotechnology application to significantly improve the development of preventive medicine, medical diagnosis, and therapeutic management. According to its enormous potential in medicine and medical technologies, the actual directions of nanomedicine are represented by the development of the basic sciences experiments according to the multidisciplinary vision of nanoscience, and training programs especially for young researchers, and moreover to provide human resources to private industry. Nanomedicine represents a medical priority today, with many countries developing new plans to improve research in this field.
0 Comments
Leave a Reply. |